key: cord-0427609-qgzc1moh
authors: Flaxman, S.; Whittaker, C.; Semenova, E.; Rashid, T.; Parks, R.; Blenkinsop, A.; Unwin, H. J. T.; Mishra, S.; Bhatt, S.; Gurdasani, D.; Ratmann, O.
title: Covid-19 is a leading cause of death in children and young people ages 0-19 years in the United States
date: 2022-05-25
journal: nan
DOI: 10.1101/2022.05.23.22275458
sha: 2004b2c47f120102f5d047189063ff700a777ddf
doc_id: 427609
cord_uid: qgzc1moh

Covid-19 has caused more than 1 million deaths in the US, including at least 1,433 deaths among children and young people (CYP) aged 0-19 years. Deaths among US CYP are rare in general, and so we argue here that the mortality burden of Covid-19 in CYP is best understood in the context of all other causes of CYP death. Using publicly available data from the National Center for Health Statistics, and comparing to mortality in 2019, the immediate pre-pandemic period, we find that Covid-19 is a leading cause of death in CYP aged 0-19 years in the US, ranking #9 among all causes of deaths, #5 in disease related causes of deaths (excluding accidents, assault and suicide), and #1 in deaths caused by infectious / respiratory diseases. Due to the impact of mitigations such as social distancing and our comparison of a single disease (Covid-19) to groups of causes such as deaths from pneumonia and influenza, these rankings are likely conservative lower bounds. Our findings underscore the importance of continued vaccination campaigns for CYP over 5 years of age in the US and for effective Covid-19 vaccines for under 5 year olds.

As of May 2022, more than 1 million individuals have died of Covid-19 in the US. In children and young people (CYP) aged 0-19 years, data from the National Center for Health Statistics (NCHS) 1 indicate there were 1,433 deaths for which Covid-19 was the underlying cause of death (March 1, 2020-April 30, 2022). This is equivalent to 1.7 deaths per 100,000 population in this age group and an annualized rate of 0.8 per 100,000. The overall risk of death from Covid-19 in CYP is markedly reduced compared to other age groups in the US, e.g. 0.8 per 100,000 compared to a death rate of 89 per 100,000 population in 50-54 year olds. However, we argue here that in US CYP, deaths from all causes are rare (49.4 per 100,000 in 2019 for 0-19 year olds; 25.0 per 100,000 for 1-19 year olds), and so the mortality burden of Covid-19 is best understood by comparing it to other significant causes of CYP mortality from a recent pre-Covid-19 period.

We obtained leading causes of death by age group in 2019 from CDC Wonder 2 and compared these to cumulative and annualized Covid-19 mortality spanning March 1, 2020-April 30, 2022. Cumulative mortality is a useful comparison as the first two years of the pandemic included significant non-pharmaceutical interventions which limited spread in the pre-Omicron period 3 , while annualized mortality may represent a lower bound on the future burden in the absence of widespread vaccination in pediatric age groups. To determine pediatric death rates by cause of death, we used 2020 population size estimates by single year of age from the US Census Bureau 4 . We note that NCHS's leading causes of death group together many individual ICD codes, while Covid-19 deaths count only those for which a single ICD cause (U07.1) was the underlying cause of death; we are therefore comparing the direct effect of a single pathogen (SARS-CoV-2) to groupings of multiple diseases. Therefore, these rankings should be seen as conservative, especially in a situation of unmitigated spread.

Like many diseases, pediatric Covid-19 death rates follow a U-shape in the US (cumulative death rates, March 1, 2020-April 30, 2022, Figure 1 ). Cumulative Covid-19 death rates peaked in infants aged <1 year at 7.2 deaths per 100,000 population. The cumulative Covid-19 death rate was 1.6 per 100,000 in 1-year old children, below 1 per 100,000 in children aged 2-12, gradually increasing to 3.9 per 100,000 in 18-year olds.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 25, 2022. ;

Considering the marked, age-specific U-shape in pediatric Covid-19 death rates, we next compared the burden of Covid-19 to other causes of death in five age brackets: <1 year, 1-4 years, 5-9, 10-14, and 15-19 years 1 . Overall, Covid-19 ranks as the #7 (cumulative) and #9 (annualized) pediatric cause of death in US CYP aged 0-19 (Supplementary Table S1 ). Rankings disaggregated by age group are shown in Table 1 , demonstrating that Covid-19 ranks consistently in the top 10 causes of death in all of the pediatric age groups. Cumulative ranks are: #4 (<1 year old), #5 (1-4 year olds), #5 (5-9 year olds), #4 (10-14 year olds), and #4 (15-19 year olds). Annualized ranks are: #8 (<1 year old), #7 (1-4 year olds), #6 (5-9 year olds), #6 (10-14 year olds), and #5 (15-19 year olds).

The higher-ranking causes of pediatric deaths comprised perinatal conditions, congenital malformations or deformations, accidents, assault, diseases of the heart, malignant neoplasms, suicide, and influenza and pneumonia. Excluding causes of death unrelated to disease (accidents, assault and suicide), Covid-19 ranked as the #5 annualized cause of death in US CYP aged 0-19 (Supplementary Table S1 ). Considering infectious / respiratory diseases only, Covid-19 ranked as the #1 cause of death in US CYP aged 0-19 (Supplementary Table S2 ). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2022. ; https://doi.org/10.1101/2022.05.23.22275458 doi: medRxiv preprint

Early on in the Covid-19 pandemic, comparisons of Covid-19 disease severity between age groups were a vital tool for appropriately allocating limited resources and prioritizing vaccination campaigns. However, long-term public health planning and management needs to be informed by the leading causes of deaths within each age group. We have shown that Covid-19 was a leading cause of death in CYP aged 0-19 years in the US between March 2020 to April 2022, ranking #9 among all causes of deaths, #5 in disease related causes of deaths (excluding accidents, assault and suicide), and #1 in deaths caused by infectious / respiratory diseases. These findings need to be considered in the context of several limitations. Analyses of excess deaths have suggested under-reporting bias in Covid-19 deaths 5 . The criteria for determining Covid-19 deaths also vary across the US. Finally, some of the cause of death categories vary in specificity, for example, the category of deaths from "influenza and pneumonia" combines a variety of causes, to which SARS-CoV-2 would be a contributing factor 6 . Relatedly, we only consider Covid-19 as an underlying (and not contributing) cause of death, but Covid-19 amplifies the severe impacts of other diseases. It is thus likely that the burden of Covid-19 has been larger in CYP aged 0-19 than our analyses suggest.

In summary, we find that Covid-19 is now a leading cause of death for CYP aged 0-19 in the US. A future variant capable of displacing Omicron will, by definition, have a growth advantage over Omicron, and there is no guarantee that its intrinsic severity will be reduced 7 . Our findings underscore the importance of continued vaccination campaigns for children ≥5 years in the US 8 and for effective Covid-19 vaccines for under 5 year olds. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2022. ; Table 1 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2022. ; https://doi.org/10.1101/2022.05.23.22275458 doi: medRxiv preprint Ethics According to HRA decision tools (http://www.hra-decisiontools.org.uk/research/), our study is considered Research, and according to the NHS REC review tool (http://www.hra-decisiontools.org.uk/ethics/), we do not need NHS Research Ethics Committee (REC) review, as we only used (1) publicly available, (2) anonymized, and (3) aggregated data outside of clinical settings. Funding ES and SF acknowledge funding from the EPSRC (EP/V002910/2), OR from the MRC (MR/V038109/1). SM and SB acknowledge funding from the Novo Nordisk Young Investigator Award (NNF20OC0059309). CW acknowledges funding from the MRC DTP that supports his PhD studies (Award Ref 1975152) . This research was funded in whole or in part by EPSRC (EP/V002910/2). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript (AAM) version arising from this submission.

Provisional COVID-19 Death Counts by Age in Years

Underlying cause of death

Estimated US Infection-and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations

Under-reporting of deaths limits our understanding of true burden of covid-19

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

All data and R scripts for replicating the results in this manuscript are available from: https://github.com/flaxter/covid19pediatric/